Sugi Predict

Sugi Predict / Compounds / SCHEMBL2115557

SCHEMBL2115557

SCHEMBL2115557

Cc1cc(=O)c(OCc2ccccc2)c(CO)o1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IDH1 O75874 1/20 0.50
▸ LMNA P02545 2/20 0.49
▸ GAA P10253 1/20 0.49
▸ POLB P06746 1/20 0.46
▸ ALDH1A1 P00352 2/20 0.43
▸ SMN1; SMN2 Q16637 2/20 0.43
▸ HPGD P15428 2/20 0.43
▸ HTT P42858 2/20 0.43
▸ MEN1 O00255 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ CREB1 P16220 1/20 0.43
▸ GSTP1 P09211 1/20 0.42
▸ NPC1 O15118 3/20 0.42
▸ PKM P14618 2/20 0.42
▸ RAB9A P51151 2/20 0.42
▸ MAPT P10636 1/20 0.42
▸ MAOB P27338 4/20 0.41
▸ MMP2 P08253 1/20 0.41
▸ ACHE P22303 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6997480 0.86 LMNA (0.49) IDH1LMNAGAAPOLBALDH1A1
SCHEMBL2592753 0.86 LMNA (0.49) IDH1LMNAGAAPOLBALDH1A1
SCHEMBL7622844 0.84 KDM4E (0.48) LMNAGAAPOLBALDH1A1MEN1
SCHEMBL6997976 0.84 LMNA (0.47) IDH1LMNAGAAPOLBALDH1A1
SCHEMBL16921605 0.84 LMNA (0.44) IDH1LMNAGAAPOLBALDH1A1
SCHEMBL15910022 0.82 LMNA (0.61) IDH1LMNAGAAPOLBALDH1A1
SCHEMBL15910031 0.82 IDH1 (0.50) IDH1LMNAGAAPOLBALDH1A1
SCHEMBL4318851 0.82 CREB1 (0.42) IDH1LMNAGAAPOLBALDH1A1
SCHEMBL18837875 0.81 ALDH1A1 (0.43) LMNAGAAPOLBALDH1A1SMN1; SMN2
SCHEMBL10290053 0.81 CREB1 (0.41) LMNAGAAPOLBALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114736155-B ALA hybrid 3-hydroxypyridone derivative, and preparation method and application thereof 浙江工业大学 2023-12-05 — — CN disclosed
CN-113121423-B ALA hybrid 3-hydroxypyridone derivative and preparation method and application thereof 浙江工业大学 2022-07-22 — — CN disclosed
CN-114736155-A ALA hybrid 3-hydroxypyridone derivative and preparation method and application thereof 浙江工业大学 2022-07-12 — — CN disclosed
CN-113121423-A ALA hybrid 3-hydroxypyridone derivative and preparation method and application thereof 浙江工业大学 2021-07-16 — — CN disclosed
CN-108191746-B Hydroxypyridones compound and preparation method and application thereof 暨南大学 2020-06-16 — — CN disclosed
EP-2637705-B1 CONJUGATES AND THEIR USES IN MOLECULAR IMAGING KING S COLLEGE LONDON (GB) 2017-03-29 — — EP disclosed
EP-2637705-B1 CONJUGATES AND THEIR USES IN MOLECULAR IMAGING KING S COLLEGE LONDON (GB) 2017-03-29 — — EP disclosed
US-20170066754-A1 ANTIVIRAL AGENT SHIONOGI & CO., LTD. (JP) 2017-03-09 — — US disclosed
US-20170066754-A1 ANTIVIRAL AGENT SHIONOGI & CO., LTD. (JP) 2017-03-09 — — US disclosed
US-9572813-B2 Antiviral agent SHIONOGI & CO., LTD. (JP) 2017-02-21 — — US disclosed
US-6506911-B2 Reacting a 2-(1-hydroxyalkyl)-3-hydroxypyran-4(1H)one compound with benzaldehyde dimethyl acetal to form 8-oxo-4,8-dihydro-2-phenyl-4h(3,2-d)-m-dioxin, reacting it with an amine compound to form an intermediate, then reducing BTG INTERNATIONAL LIMITED (GB) 2003-01-14 — — US disclosed
EP-0984934-B1 NOVEL ORALLY ACTIVE IRON (III) CHELATORS BTG INTERNAT LTD COMPANY NO 26 (GB) 2003-01-08 — — EP disclosed
US-6476229-B1 Processes for the manufacturing of 3-hydroxy-N,1,6-trialkyl-4-oxo-1,4-dihydropyridine-2-carboxamide APOTEX, INC. (CA) 2002-11-05 — — US disclosed
US-6472532-B1 INEXPENSIVE METHOD USING KOJIC ACID AS SAFE STARTING MATERIAL FOR SYNTHESIS OF ORALLY ACTIVE IRON CHELATORS APOTEX, INC. (CA) 2002-10-29 — — US disclosed
US-6448273-B1 SUCH AS 2,6-DIMETHOXYMETHYL-1-METHYL-3-BENZYLOXPYRIDIN-4(1H)-ONE; TREATING DISORDERS ASSOCIATED WITH IRON DISTRIBUTION AND IRON DEPENDANT PARASITES; REDUCED LEVELS OF ACTIVE AGENT; SELECTIVE TARGETING TO TISSUES AND LIVER; METABOLIC STABILITY BTG INTERNATIONAL LIMITED (GB) 2002-09-10 — — US disclosed
US-6426418-B1 REACTING A 3-OXY-2-HYDROXYALKYL-4H-PYRAN-4-ONE DERIVATIVE WITH SODIUM HYPOCHLORITE SOLUTION, POTASSIUM BROMIDE, TEMPO, AND A PHASE TRANSFER CATALYST TO PRODUCE A 3-OXY-2-CARBOXY-4H-PYRAN-4-ONE DERIVATIVE APOTEX, INC. (CA) 2002-07-30 — — US disclosed
US-20020068758-A1 Novel orally active iron (III) chelators BTG INTERNATIONAL LIMITED. 2002-06-06 — — US disclosed
US-6335353-B1 3-HYDROXYPYRIDIN-4-ONE DERIVATIVE; IRON DEFICIENCY ANEMIA AND THALASSEMIA TREATMENT BTG INTERNATIONAL LIMITED (GB) 2002-01-01 — — US disclosed
EP-0984934-A1 NOVEL ORALLY ACTIVE IRON (III) CHELATORS BTG INTERNATIONAL LIMITED (Company No. 2664412) (GB) 2000-03-15 — — EP disclosed
WO-1998054138-A1 NOVEL ORALLY ACTIVE IRON (III) CHELATORS BTG INTERNATIONAL LIMITED (GB) 1998-12-03 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020068758-A1 Novel orally active iron (III) chelators HAMP, HRH2, GRHPR IDH1 808/4885LMNA 2634/4885GAA 1367/4885
US-20170066754-A1 ANTIVIRAL AGENT ZC3HAV1, ZC3HAV1L, CCNI IDH1 147/4885LMNA 2945/4885GAA 1442/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.